Benefits of Glucagon-Like Peptide 1 Receptor Agonists in Kidney Transplant Recipients

被引：0

作者：

Garcia, Valencia Oscar Alejandro ^{[1
]}

Sahi, Sukhdeep Singh ^{[1
]}

Na, Jie ^{[1
]}

Smith, Byron H. ^{[1
]}

Budhiraja, Pooja ^{[2
]}

Diwan, Tayyab S. ^{[1
]}

Issa, Naim S. ^{[1
]}

Denic, Aleksandar ^{[1
]}

Abdelrheem, Ahmed ^{[1
]}

Wadei, Hani ^{[3
]}

Kudva, Yogish C. ^{[1
]}

Kukla, Aleksandra ^{[1
]}

机构：

[1] Mayo Clin Minnesota, Rochester, MN USA

[2] Mayo Clin Arizona, Scottsdale, AZ USA

[3] Mayo Clin Florida, Jacksonville, FL USA

来源：

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2024年 / 35卷 / 10期

关键词：

D O I：

10.1681/ASN.2024dtfe7jaj

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

TH-PO743

引用

页数：2

共 50 条

[41] Perioperative Implications of Glucagon-like Peptide-1 Receptor Agonists
Wolfe, Rachel C.
JOURNAL OF PERIANESTHESIA NURSING, 2024, 39 (06) : 1108 - 1110
[42] Renoprotective mechanisms of glucagon-like peptide-1 receptor agonists
Chen, J.
Cooper, M. E.
Coughlan, M. T.
DIABETES & METABOLISM, 2025, 51 (03)
[43] NEPHROPROTECTIVE POTENTIAL OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS
Shamhalova, Minara S.
Sklyanik, Igor A.
Shestakova, Marina V.
DIABETES MELLITUS, 2020, 23 (01): : 56 - 64
[44] Emerging glucagon-like peptide 1 receptor agonists for the treatment of obesity
Jepsen, Mathies M.
Christensen, Mikkel B.
EXPERT OPINION ON EMERGING DRUGS, 2021, 26 (03) : 231 - 243
[45] Glucagon-Like Peptide 1 Receptor Agonists: A Medication for Obesity Management
Taha, Mohamad B.
Yahya, Tamer
Satish, Priyanka
Laird, Rachel
Agatston, Arthur S.
Cainzos-Achirica, Miguel
Patel, Kershaw V.
Nasir, Khurram
CURRENT ATHEROSCLEROSIS REPORTS, 2022, 24 (08) : 643 - 654
[46] Glucagon-like peptide-1 receptor agonists in neoplastic diseases
Ji, Lisan
He, Xianzhen
Min, Xinwen
Yang, Handong
Wu, Wenwen
Xu, Hao
Chen, Jun
Mei, Aihua
FRONTIERS IN ENDOCRINOLOGY, 2024, 15
[47] Renal protection with glucagon-like peptide-1 receptor agonists
Vitale, Martina
Haxhi, Jonida
Cirrito, Tiziana
Pugliese, Giuseppe
CURRENT OPINION IN PHARMACOLOGY, 2020, 54 : 91 - 101
[48] Clinical pharmacology of glucagon-like peptide-1 receptor agonists
Sfairopoulos, Dimitrios
Liatis, Stavros
Tigas, Stelios
Liberopoulos, Evangelos
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2018, 17 (03): : 333 - 350
[49] Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
Kang, Yu Mi
Jung, Chang Hee
ENDOCRINOLOGY AND METABOLISM, 2016, 31 (02) : 258 - 274
[50] Glucagon-Like Peptide 1 Receptor Agonists in Alzheimer’s Disease
Xue Qiao-Qiao Wang
Tian-Tian Yan
Ling-Hui Wang
Neurochemical Journal, 2023, 17 : 243 - 246

← 1 2 3 4 5 →